Moderna Inc.
MRNA | NASDAQ
$182.82
+$9.88 (+5.71%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -2.82B | -3.56B | -4.71B | 8.36B | 12.2B | -747.06M |
Depreciation & Amortization | 215M | 189M | 621M | 348M | 232M | 93M |
Stock-Based Compensation | 483M | 429M | 305M | 226M | 142M | 93M |
Other Working Capital | 224M | -626M | -1.39B | -5.98B | 4.28B | 4B |
Other Non-Cash Items | -3M | 17M | -19M | 59M | 54M | 558K |
Deferred Income Tax | n/a | n/a | 828M | -559M | -318M | 10.42M |
Change in Working Capital | 254M | -78M | -139M | -3.46B | 1.31B | 2.58B |
Operating Cash Flow | -1.87B | -3B | -3.12B | 4.98B | 13.62B | 2.03B |
Capital Expenditures | -192M | -1.05B | -707M | -400M | -284M | -67.45M |
Cash Acquisitions | n/a | n/a | -85M | n/a | n/a | n/a |
Purchase of Investments | -5.77B | -6.53B | -3.78B | -11.44B | -12.65B | -2.96B |
Sales Maturities Of Investments | 7.92B | 9.53B | 8.78B | 6.7B | 4.44B | 1.35B |
Other Investing Acitivies | -10M | n/a | n/a | -40M | -30M | n/a |
Investing Cash Flow | 1.95B | 1.95B | 4.21B | -5.18B | -8.52B | -1.67B |
Debt Repayment | 539M | -10M | -270M | -184M | -140M | -6M |
Common Stock Repurchased | n/a | n/a | -1.15B | -3.33B | -857M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19M | n/a | n/a | n/a | n/a | 193K |
Financial Cash Flow | 593M | 56M | -1.38B | -3.45B | -873M | 2.03B |
Net Cash Flow | 668M | -999M | -289M | -3.64B | 4.22B | 2.39B |
Free Cash Flow | -2.07B | -4.06B | -3.83B | 4.58B | 13.34B | 1.96B |
Adj. Free Cash Flow | -2.55B | -4.48B | -4.13B | 4.36B | 13.19B | 1.87B |
Maintenance CapEx | -192M | -1.05B | -707M | -260.97M | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -139.03M | -284M | -67.45M |
Owner Earnings | -2.07B | -4.06B | -3.83B | 4.72B | 13.62B | 2.03B |
Add to Watchlist
Select watchlists to add or remove MRNA